Objective-Hypoxia is considered a key factor in the progression of atherosclerotic lesions. Low-density lipoprotein receptor-related protein (LRP1) plays a pivotal role in the vasculature. The aim of this study was to investigate the effect of hypoxia on LRP1 expression and function in vascular smooth muscle cells (VSMC) and the role of hypoxia-inducible factor-␣ (HIF-1␣).
H ypoxia plays a pivotal role in the pathophysiology of cancer, myocardial infarction, and atherosclerosis. Arterial wall thickness associated with atherosclerotic plaque progression reduces the oxygen supply in certain areas of the vascular intima. 1, 2 Hypoxia is present in human advanced atherosclerotic lesions and correlates with the presence of angiogenesis and thrombus. 3, 4 Most of the cells in hypoxic areas of atherosclerotic plaques respond by altering the expression of genes involved in vasculogenesis, angiogenesis, inflammation, and lipid deposition. [5] [6] [7] [8] [9] [10] [11] These genes are activated through hypoxia-inducible factor-1 complex (HIF-1). The HIF-1␣ subunit is subjected to quick oxygendependent proteasomal degradation through hydroxylation of proline residues by hydroxylases. [12] [13] [14] Under low oxygen tensions, HIF-1␣ accumulates and heterodimerizes with the constitutively expressed beta subunit, allowing the HIF-1 complex to bind to hypoxia response element (HRE) sequences in target promoters. 15 It has been reported that HIF-1␣ accumulation in macrophages promotes foam cell formation and atherosclerosis. 16 In experimental models of hypercholesterolemia and hypertension, HIF-1␣ is also associated with vascular smooth muscle cells (VSMC). 17, 18 Hypoxia modulates key events for VSMC functionality, such as proliferation/migration 19, 20 and lipid accumulation. 21 Lowdensity lipoprotein (LDL) aggregation and fusion (aggregated LDL [agLDL]), one of the main inducers of VSMC-foam cell formation, [22] [23] [24] is enhanced under hypoxic conditions. 25 Lowdensity lipoprotein receptor-related protein 1 (LRP1), the lipoprotein receptor that binds and internalizes agLDL, 23, 24 is upregulated by hypercholesterolemia 26 and hypertension. 27 LDL stimulates LRP1 transcription through the downregulation of sterol regulatory element binding protein (SREBP). 26 SREBP-1 and SREBP-2 transcription factors negatively modulate LRP1 transcription in human VSMC. 28, 29 LRP1 upregulation induced by cardiovascular risk factors may contribute to LRP1 overexpression found in advanced atherosclerotic lesions. 30 -32 It is unknown whether hypoxia may modulate LRP1 expression in human atherosclerotic plaques and, if so, which transcription factors are involved.
The aim of this work was to investigate the effect of hypoxia on the expression and function of vascular LRP1 and the molecular mechanism involved in this effect.
Materials and Methods

Cell Cultures
VSMC were isolated by a modification of the explant technique, as previously described. [22] [23] [24] Details are provided in the supplemental material, available online at http://atvb.ahajournals.org.
Small Interference RNA-Mediated Gene Silencing of LRP1 and HIF-1␣ in Human VSMC
To inhibit LRP1 expression in human VSMC, cells were transiently transfected with annealed small interference RNA (siRNA-LRP1) synthesized by Ambion according to our previously published LRP1 target sequences. 23, 24 Details are provided in the supplemental material.
LDL Isolation and Modification
agLDL was prepared by vortexing LDL in PBS at room temperature. The formation of LDL aggregates was performed as previously described. 33 The ultrastructure of agLDL obtained by vortexing was similar to that of LDL modified by versican, 24 1 of the main chondroitin sulfate proteoglycans structuring the arterial intima. Details are provided in the supplemental material.
Statistical Analysis
Results are expressed as meanϮSEM and the number of experiments is shown in every case. Statistical differences between control and treated groups were analyzed by the nonparametric Mann-Whitney test for paired data. A probability value of 0.05 or less was considered significant.
Results
Hypoxia Upregulates LRP1 Expression in Human VSMC
Real-time PCR results ( Figure 1A ) demonstrated that hypoxia induced VSMC-LRP1 mRNA expression in a time-dependent manner. Maximal LRP1 mRNA expression (1.8-fold approximately) was reached after 60 minutes of hypoxia and decayed after 16 hours. LDL receptor was slightly induced by hypoxia within 1 hour and decayed under basal levels at 8 and 16 hours of hypoxia ( Figure 1B ). SREBP-1 and SREBP-2 mRNA expression levels were significantly decreased by 26Ϯ3% and 54Ϯ2.5%, respectively, after 16 hours of hypoxia (see Supplemental Table I ). Confocal microscopy experiments demonstrated higher levels of LRP1 staining in the cytoplasm of hypoxic VSMC than in normoxic VSMC ( Figure 1C ). Quantification of the surface covered by fluorescence using National Institutes of Health Image software showed that hypoxic VSMC had approximately 1.7-fold higher staining than normoxic cells (hypoxia, 250Ϯ56, versus normoxia, 150Ϯ22 pixels 2 /cell) (Figure 1D) . Western blot analysis demonstrated that hypoxia increased both LRP1 protein and HIF-1␣ expression levels, although at different time points ( Figure 1E ). LRP1 was upregulated from 1.35-fold at 6 hours to 2-fold at 24 hours of hypoxia ( Figure 1E and 1F). In contrast, HIF-1␣ protein levels were maximally upregulated at shorter times ( Figure 1E ). These results showed differences in the time-course pattern of hypoxic LRP1 and HIF-1␣ protein upregulation.
Hypoxia Does Not Alter mRNA or Protein Stability
To elucidate whether hypoxia may influence LRP1 mRNA stability, arrested VSMC were preexposed to normoxia or hypoxia for 4 hours. Actinomycin D (4.5 g/mL) was then added, and cell cultures were returned to normoxia or hypoxia. Cells were harvested at various time points after actinomycin D treatment and processed to analyze LRP1 mRNA expression levels. LRP1 mRNA expression remained constant for 6 hours of actinomycin D treatment (data not shown). In contrast, the percentage of initial LRP1 mRNA strongly decayed after 12 hours of actinomycin treatment (normoxia: to 69Ϯ0.5%; hypoxia: to 67Ϯ5%) ( Figure 2A ). To confirm that LRP1 protein upregulation by hypoxia was dependent on transcription, untreated or actinomycin-treated VSMC were exposed to hypoxia. As shown in Figure 2B , hypoxic LRP1 upregulation was completely abrogated in the presence of actinomycin D. To measure protein stability, human VSMC were preexposed to normoxia or hypoxia followed by addition of cycloheximide to block translation. LRP1 expression remained constant for 12 hours of cycloheximide treatment (data not shown). However, the percentage of initial LRP1 protein strongly decayed from 12 hours (normoxia: to 70Ϯ3.42%; hypoxia: to 69Ϯ4.67%) to 32 hours (normoxia: to 32Ϯ3.76%; hypoxia: to 29Ϯ4.45%) ( Figure  2C ). These findings suggest that the half-life of LRP1 protein is 24 hours, independent of normoxic or hypoxic conditions. Additionally, these results suggest that both transcriptional and translational activities are required for hypoxic upregulation of LRP1.
Hypoxia Increases HIF-1␣ Levels and HIF-1␣ Binding to LRP1 Promoter in Human VSMC
Analysis of the LRP1 gene promoter using MatInspector software (Genomatix) indicated the presence of 2 HRE sites (CACG) at Ϫ1072/Ϫ1069 (HRE-2) and Ϫ695/Ϫ692 (HRE-1) ( Figure 3A) .
Western blot analysis showed that VSMC-HIF-1␣ protein levels were significantly induced within 30 minutes of cellular exposure to hypoxia and reached maximal levels after 2 hours of continuous exposure to hypoxia ( Figure 3B ). ChIP assays performed in human VSMC demonstrated that HIF-1␣ binds to the HRE-1 and HRE-2 sequences of the LRP1 promoter in vivo ( Figure 3C ). Although HIF-1␣ binding to both HRE sites was already detected at 30 minutes of hypoxia, maximal binding to both HRE-sites was reached after 2 hours of hypoxia. HIF-1␣ binding to HRE-2 was higher than to HRE-1 at 2 and 4 hours. As expected, we found a strong binding of HIF-1␣ to vascular endothelial growth factor promoter (positive control) after 30 minutes of hypoxia ( Figure 3C ).
Hypoxia Increases LRP1 Promoter Transcriptional Activity Through Two HRE-1 and HRE-2 Sequences
To investigate the role of HRE-1 and HRE-2 sites in the hypoxic modulation of the LRP1 promoter, we performed transient transfection assays using LRP1 promoter constructions with the 2 HRE sites (Ϫ1305 to ϩ341), with HRE-1 site (Ϫ803 to ϩ341), without HRE sites (Ϫ131 to ϩ341), and with their corresponding mutated constructions.
As shown in Supplemental Figure IA , hypoxia (24 hours) increased the transcriptional activity of the wild LRP1 promoter by 3.5-fold and that of the HRE-1-mutated LRP1 promoter by 2.6-fold. However, it increased the transcriptional activity of HRE-2-mutated LRP1 only moderately (less than 2-fold), and it did not exert any effect on the construction Ϫ131/ϩ341 without HRE sequences.
In agreement with these results, HIF-1␣ overexpression, which strongly raised HIF-1␣ accumulation (Supplemental Figure IB) , triggered a 2-fold increase in the transcriptional activity of the wild LRP1 promoter. In contrast, it increased the transcriptional activity of HRE-1 or HRE-2-mutated Figure 2 . Effect of hypoxia on mRNA and LRP1 protein stability. A, Arrested VSMC were preexposed to normoxia or hypoxia for 4 hours. Actinomycin D (4.5 g/mL) was then added, and cell cultures were returned to normoxia and hypoxia. Cells were harvested at the indicated times. LRP1 mRNA was analyzed by real-time PCR. The value of LRP1 expression at time 0 hours was set at 100% and used to determine the percentage of LRP1 remaining after actinomycin D addition. Results are expressed as meanϮSEM of 2 independent experiments performed in triplicate. B, VSMC were incubated in the absence or presence of actinomycin (4.5 g/mL) and exposed to normoxia or hypoxia for 16 hours. Cells were then harvested and processed for Western blot analysis as explained in Methods. Results are expressed as meanϮSEM of 2 independent experiments performed in triplicate. *PϽ0.05 vs normoxic cells. C, VSMC were preexposed to normoxia or hypoxia for 24 hours, followed by incubation with cycloheximide (100 mol/L) for the indicated times. Unchanged levels of ␤-actin are shown as loading control. Line graphs show the percentage of the value before the addition of cycloheximide. Results are expressed as meanϮSEM of 2 independent experiments performed in triplicate. Arrows indicate the time for 50% decay in protein (half-life).
LRP1 only 1.6-and 1.3-fold, respectively (Supplemental Figure IC) . HIF-1␣ overexpression did not exert any significant effect on the activity of construction Ϫ131/ϩ341 without HRE sequences. These data suggest that both HRE sequences play a role in the upregulatory effect of hypoxia on LRP1 promoter, although the HRE located at Ϫ1072/Ϫ1069 (HRE-2) seems to be more relevant.
Hypoxia Increases LRP1-Mediated Aggregated LDL Uptake by Human VSMC
To analyze the functional consequences of hypoxia-induced LRP1 overexpression, we tested the effect of hypoxia on the uptake of agLDL, an LRP1 ligand in human VSMC. [22] [23] [24] We compared the effect of increasing concentrations of native LDL ( Figure 4A ) and agLDL ( Figure 4B ) (0, 25, 50, and 100 g/mL) on the cholesteryl ester (CE) content of VSMC exposed to normoxic or hypoxic conditions. Hypoxia increased CE accumulation derived from agLDL (100 g/mL) from 35.7Ϯ0.7 to 50.5Ϯ1.6 g CE/mg protein ( Figure 4B and 4C) . In contrast, hypoxic conditions did not significantly alter CE accumulation derived from native LDL at any tested concentration ( Figure 4A and 4C). Free cholesterol intracellular content of VSMC was not altered by lipoprotein treatment under either normoxic or hypoxic conditions ( Figure 4A and 4B) . However, the VSMC-triglyceride (TG) intracellular content ( Figure 4A , 4B, and 4D) was significantly increased by approximately 1.5-fold in hypoxic Arrested VSMC were exposed to either normoxia or hypoxia for 0.5, 2, 4, and 8 hours. A, Schematic representation of the LRP1 promoter region containing 2 putative HRE sequences at Ϫ1072/Ϫ1069 (HRE-2) and Ϫ695/Ϫ692 (HRE-1) indicated in bold and underlined text. B, Representative Western blot analysis showing HIF-1␣ protein levels in VSMC incubated for increasing times under hypoxia. Unchanged levels of ␤-actin are shown as loading control. C, ChIP assay shows the relative in vivo association of HIF-1␣ to the HRE-1 and the HRE-2 sequence of LRP1 promoter. Chromatin was sheared by sonication, and immunoprecipitations were performed with an anti-HIF-1␣ antibody or a nonspecific goat IgG as a negative control. The relative in vivo binding of HIF-1␣ was quantified by real-time PCR using LRP1 promoter-specific primers. PCR reactions using total input DNA (saved before immunoprecipitation) were also carried out. The threshold cycle (Ct) of immunoprecipitated samples (with specific anti-HIF-1␣ antibody or with nonspecific IgG) was normalized to the Ct of total input DNA (⌬Ct). Results obtained with specific anti-HIF-1␣ antibody were then normalized to those obtained with nonspecific IgG antibodies (⌬⌬Ct). Results are expressed as meanϮSEM of 3 experiments performed in duplicate.*PϽ0.01 vs normoxic controls. VEGF indicates vascular endothelial growth factor. VSMC, independently of the absence or presence of LDL. This result can be explained by the upregulatory effect of hypoxia on TG biosynthesis previously described in macrophages. 11 To demonstrate that LRP1 is responsible for the hypoxic-CE overaccumulation in human VSMC exposed to agLDL, we compared the fold change in the intracellular lipid content induced by hypoxia in control, siRNA-random, and siRNA-LRP1-treated VSMC. As shown in Supplemental Figure IIA , LRP1 was completely knocked down in siRNA-LRP1-treated VSMC. Hypoxia increased CE accumulation by 1.72-fold in siRNA-random-treated VSMC but failed to induce any alteration on CE accumulation in siRNA-LRP1 treated VSMC (Supplemental Figure IIB) . As expected, hypoxic-TG increase was similar in siRNA-random and siRNA-LRP1-treated VSMC and independent of the absence or presence of agLDL (data not shown). No differences were found in the intracellular cholesterol content of control (cells nucleofected without siRNA) and siRNA-random treated VSMC.
Hypoxia Fails to Increase LRP1 Expression and CE Accumulation From agLDL in HIF-1␣-Deficient VSMC
To ascertain the involvement of HIF-1␣ on the hypoxic upregulation of LRP1, we inhibited the expression of HIF-1␣ in human VSMC by nucleofection with specific siRNA-HIF-1␣. siRNA-HIF-1␣ but not siRNA-random completely prevented the 4.2-fold increase in HIF-1␣ protein levels induced by hypoxia in human VSMC ( Figure 5A ). Hypoxia did not exert any effect on LRP1 protein ( Figure 5B ) or LRP1 mRNA ( Figure 5C ) expression in HIF-1␣-deficient cells, but it significantly increased LRP1 expression in control and siRNA-random-treated VSMC Accordingly, hypoxia increased intracellular CE content of control and siRNArandom-VSMC 1.8-fold, but it failed to increase the CE content of HIF-1␣-deficient VSMC ( Figure 5D ). As expected, TG content was strongly raised in control and siRNA-random hypoxic VSMC but not in HIF-1␣-deficient VSMC. These results demonstrate that both LRP1 upregula- Comparison of the effect of native LDL (nLDL) and agLDL on the CE, TG, and free cholesterol content of human VSMC exposed to normoxia or hypoxia. Arrested VSMC cultured under normoxic or hypoxic conditions for 24 hours were exposed to 0, 25, 50, and 100 g/mL of nLDL (A) or agLDL (B) for the last 12 hours. Cells were then collected, and lipid extraction was performed as explained in Methods. Bar graphs show the quantification of CE (C) and TG (D) bands. Results are expressed as micrograms of cholesterol per milligram of protein and shown as meanϮSEM of 3 experiments performed in duplicate. *PϽ0.05 vs normoxic controls. 
Association of LRP1 and HIF-1␣ to VSMC in Human Advanced Atherosclerotic Lesions
To know whether LRP1 upregulation by HIF-1␣ occur in VSMC of atherosclerotic plaques, we performed immunohistochemical analysis of advanced atherosclerotic lesions. Figure 6A shows a representative Masson trichrome staining of an advanced atherosclerotic plaque and a normal area used as a control. LRP1 and HIF-1␣ were highly expressed in deeper areas of the intima coinciding with cells positive for ␣-actin (specific VSMC marker) in human advanced atherosclerotic plaques. In contrast, a slight LRP1 and HIF-1␣ staining was observed in control areas. In double immunofluorescence exper-iments, specific fluorescence for LRP1 and HIF-1␣ overlapped in vascular cells of advanced atherosclerotic plaques ( Figure 6B ).
Discussion
In lipid-enriched atherosclerotic plaques, LRP1 may contribute to lipid deposition because of its capacity to bind and internalize matrix-retained-aggregated LDL, the main modified form of LDL in the arterial intima. 36 -38 Real-time PCR and Western blot analysis from the present study demonstrate that hypoxia strongly induces LRP1 mRNA and protein expression in human VSMC as previously seen in tumoral cell lines. 39, 40 In human VSMC, maximal upregulation of LRP1 by hypoxia occurs at 1 hour at the level of mRNA and at 16 hours at the protein level. The delayed upregulation of the LRP1 protein by hypoxia seems to be due to the extremely long half-life of LRP1 protein in human VSMC. Our current data from actinomycin D experiments demonstrated that hypoxic-induced LRP1 overexpression depends on transcription because actinomycin D completely abrogated this hypoxic effect. The similarity in the transient time-course pattern of LRP1 mRNA and HIF-1␣ protein induction by hypoxia support our hypothesis that HIF-1␣ modulates LRP1 promoter transcription. The specific inhibition of HIF-1␣ almost completely prevented LRP1 mRNA and protein overexpression induced by hypoxia in human VSMC. The analysis of the 5Ј region of the human LRP1 promoter revealed that the LRP1 promoter has 2 putative HRE sites that, according to the ChIP assays, have the ability to bind HIF-1␣ in vivo. The maximum binding of HIF-1␣ to these sequences was time coincident with the maximum expression of HIF-1␣. Luciferase activity assays demonstrated that both HRE-1 and HRE-2 sequences play a pivotal role in the upregulatory effect of hypoxia and HIF-1␣ overaccumulation on LRP1 promoter activation, although HRE-2 (Ϫ1072/Ϫ1069) plays a major role. These results are in agreement with those from ChIP that showed a higher in vivo HIF-1␣ binding to the HRE-2 than to the HRE-1 sequence of the LRP1 promoter. Taken together, these results from different experimental approaches demonstrate that HIF-1␣ mediates, albeit in part, the upregulatory effect of hypoxia on LRP1 transcription.
Interestingly, we found that hypoxia also exerted a downregulatory effect on SREBP-1 and SREBP-2 levels in human VSMC. By decreasing SREBP levels, hypoxia caused a LDL receptor expression decay and likely also contributed to LRP1 upregulation. Previous results from our group demonstrated that contrary to the classical LDL receptor, LRP1 is negatively regulated by SREBPs. 28, 29 There are controversial results in the literature concerning the effect of hypoxia on SREBP expression. Although some authors report SREBP downregulation, 41 others show opposite results. 42, 43 These discrepancies have been explained by a differential hypoxic modulation of transcription factors depending on the cell type. 44, 45 Indeed, differences in the modulation of SREBPs by hypoxia explain why LRP1 is downregulated in cerebral VSMC 46 but upregulated in coronary VSMC.
Our results show that HIF-1␣ inhibition prevented not only hypoxia-inducible TG accumulation 11 but also hypoxiainducible agLDL-derived CE overaccumulation. Therefore, besides SREBPs, 26, 28, 29 HIF-1␣ also clearly contributes to modulating LRP1-mediated intracellular lipid accumulation from agLDL in human VSMC. LRP1-mediated agLDL internalization is one of the main mechanisms contributing to VSMC-foam cell formation in experimental hyperlipidemia and hypertension. [22] [23] [24] 26, 27 Interestingly, foam cells colocalize with HIF-1␣ protein in the lipidic areas of human advanced atherosclerotic lesions. 3, 4 Foam cells derive not only from macrophages but also from VSMC. 47, 48 Our immunohistochemical results show that LRP1 and HIF-1␣ colocalized in human advanced enriched atherosclerotic plaques. The upregulation of LRP1 expression by a combined effect of HIF-1␣ overexpression (induced by hypoxia) and SREBP downregulation (induced by lipid and hypoxia) may be relevant in vivo because hypoxic areas are frequently associated with lipids in advanced atherosclerotic lesions. 3, 4 Besides a carrier receptor, LRP1 is a signal transduction receptor that moves to caveolae in response to extracellular signals. 49, 50 It is thus of interest to know whether hypoxia may alter the subcellular distribution of LRP1.
In summary, results from the present study show that HIF-1␣ and LRP1 are overexpressed in hypoxic VSMC and that HIF-1␣ and LRP1 protein staining coincides with VSMC in human advanced atherosclerotic lesions. Taken together, these results demonstrate that hypoxic VSMC may contribute to the high levels of HIF-1␣ associated with foam cells in human advanced atherosclerotic lesions. 3, 4 
